All Resources

The Drug Supply Chain Security Act (DSCSA) serialization mandate is now in full effect. Every pharmaceutical distributor and 3PL must trace serialized product at the unit level and stay in sync with trading partners in real time. There are multiple ways to meet the minimum requirements — but only one approach delivers full compliance without operational disruption. Tecsys provides that solution: the most complete, warehouse-native serialization capability, built directly into core workflows so compliance happens automatically as you work.

DSCSA compliance is only the beginning. Is your warehouse ready for the challenges it brings? Without the right strategies in place, compliance can create bottlenecks, delay shipments, and lead to costly disruptions. But with the right approach, it’s an opportunity to optimize your warehouse for long-term success. This playbook helps you turn compliance into a competitive edge. By adopting best practices beyond serialization and traceability, you can safeguard your operations, protect your reputation, and enhance patient safety.

Discover essential guidelines for complying with the Drug Supply Chain Security Act (DSCSA). Learn how to enhance supply chain security and meet regulatory standards across various roles in the pharmaceutical industry.

Surescripts streamlines the patient benefits verification process for life sciences companies with a single direct connection

This case study explores how one pharmaceutical brand responded to a significant formulary loss, implementing seamless provider prior authorization strategies through CoverMyMeds to mitigate impact and maintain market share in a highly competitive class.

This eBook, From Prescribing to Pick Up: Navigating the Access & Affordability Landscape, provides a focused view into CoverMyMeds’ access and affordability solutions and how they help biopharma brands overcome patient barriers. It highlights their integrated network, innovative technology, and human support services — including prior authorization solutions, hub services, and copay assistance — designed to streamline the patient journey, improve speed to therapy, and enhance health outcomes.

See how one lab avoided $12 million research loss during an unplanned power and equipment failure.

Based on insights from over 360 life science professionals, this benchmark study examines how organizations across pharma, biotech, research, and healthcare are managing the storage and oversight of biological materials. The report reveals how leaders are balancing security, regulatory compliance, temperature control, and cost while maintaining the speed and reliability required for critical sample access.

Point of Care and PatientPoint can improve the impact that your Pharma Reps are already having.

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.

Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.

Imagine a world where clinical trials move seamlessly from concept to completion, staffing shortages are a thing of the past and patient recruitment happens at a record speed. Join Marken’s patient centric solutions expert and our featured guest for a dynamic discussion on how customizable site augmentation programs are accelerating life-saving treatments to market faster through scalable, flexible decentralized strategies. Learn practical solutions for streamlining on-site, remote or hybrid trials by matching dedicated clinical research professionals to your site’s unique needs, relieving staff burdens and empowering your team to focus on what matters most – patient care.

Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continuous -80°C temperature control and dry ice replenishment throughout an 80-hour transit – Marken activated a customized, precision-driven supply chain strategy. Navigating one of the world’s most complex regulatory landscapes for advanced therapies, success depended on flawless execution, specialized handling protocols, and seamless cross-functional collaboration. So how did Marken overcome these high-stakes challenges – ensuring the integrity of these transformative therapeutics while exceeding client expectations? Read the full case study to find out.

When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy under the strictest regulatory and temperature specifications. With precise temperature-control required at -80°C with dry ice, Marken’s teams navigated weekend scheduling, specialized package handling and final-mile complexities to ensure the vital treatment remained on schedule with white glove service from pick up to final mile delivery. Discover how Marken made it happen.

At Advanced Therapies Week 2025, Rohin Iyer, Senior Director of Global CGT Operations at Marken, sat down for an exclusive interview with Phacilitate, offering perspective on the transformative advancements, emerging challenges, and future directions shaping the advanced therapies landscape. In this compelling discussion, Rohin explores key trends, including the increasing approval rates of allogeneic and autologous therapies, the exponential growth in the cell and gene therapy sector, and the shift toward earlier use of these therapies due to their curative potential. He also shares valuable insights into the most significant challenges and opportunities facing the CGT industry in 2025 and beyond, including how Marken, UPS Healthcare Precision Logistics is navigating and contributing to the future of advanced therapies, and delivering innovative solutions designed to meet the evolving needs of the field.

Radiopharmaceuticals are transforming cancer treatment, but their short half-lives and radioactive properties demand flawless, time-critical logistics. Marken’s integrated one UPS network ensures secure, temperature-controlled and compliant delivery every time - accelerating access to these life-saving therapies.

There’s a reason your facility’s most sensitive operations are called “mission critical.” Learn how ABM’s highly technical management services can take the worry out of maintaining your most specialized systems.

Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about EM and cleanroom best practices and to see how ABM can implement industry-leading cleanroom solutions for your facility.